Josie Health Review: What We Verified Before You Pay

Independent editorial research. Educational only, not medical advice, and not medically reviewed by a clinician. We earn no commission from Josie. Our links to Josie are unpaid.

This Josie Health review found a telehealth program with four publicly listed compounded HRT options costing $269 to $299 per three-month plan. It may fit women paying cash who deliberately want compounded care, especially after hysterectomy. It is not our first pick for women with a uterus seeking systemic estrogen, FDA-approved medication, insurance billing, or a published pharmacy and strength.

That last sentence is the whole review. We will show you exactly why.

Best for: A woman paying cash who understands the compounded-versus-FDA-approved distinction, wants an asynchronous online model, and does not need Josie to supply a clearly identified oral progesterone product.

Not for you if: You want FDA-approved medication, need insurance to make care affordable, want the dispensing pharmacy and strength published before intake, or still have a uterus and want systemic estrogen without an unanswered endometrial-protection question.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

Josie at a glance	What we verified on August 18, 2026
Public HRT catalog	Four options: estradiol body cream, progesterone + estradiol body cream, estradiol patch, and progesterone + estradiol vaginal cream
Published price	$269 or $299 for a three-month plan
FDA status shown by Josie	The HRT category is labeled compounded; compounded products are not FDA-approved
Insurance	Josie does not accept insurance
HSA/FSA	Josie says some patients use these accounts and tells patients to confirm eligibility with their account provider
Labs	Not standard; Josie says lab work may be recommended
State availability	All 50 states, according to Josie
Care model	Online intake, provider review, follow-up by messaging, medication shipped if prescribed
Named clinical supervisor	Ana Lisa Carr, MD, MBA; NPI 1689841744
Published oral progesterone option	None in the public HRT catalog
Separate membership fee	None published for these plans
Decline fee	$80 only if a provider approves the care plan and the patient then declines treatment
Dispensing pharmacy	Not named publicly

The numbers that matter: 4 public HRT products · $269–$299 per three-month plan · $1,076–$1,196 for four consecutive three-month plans · $80 approved-then-decline fee · $0 separate membership fee · 50 states claimed by Josie.^[1][2][3][4]

Quick clarification: this review is about Join Josie

The company reviewed here calls itself Josie or Join Josie, at joinjosie.com. It does not consistently use the name “Josie Health,” but that is what many searchers type.

It is not Josi Health, the separate company offering online autism and ADHD evaluations. This page covers Join Josie’s hormone therapy, not its weight-management program.

Before you read one more line

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Not sure whether Josie’s trade-offs matter in your case? Find My HRT Path takes about 90 seconds and turns your uterus status, symptoms, insurance, preferred route, and state into a clearer starting point.

What does this Josie Health review conclude?

Josie is a real operating telehealth program with unusually clear three-month sticker prices and unusually unclear medication specifics. The public catalog is entirely presented as compounded, publishes no strengths, names no pharmacy, and contains no standalone oral progesterone. That makes Josie a plausible cash-pay fit for some women and the wrong starting point for others.

Here is the evidence boundary. We are not going to turn provider marketing into an independently verified fact by changing the verb tense.

Claim	Josie says	Independently verified	Still unverified
Four public HRT options	Yes	We checked all four live product pages	—
$269–$299 per three-month plan	Yes	We checked each live product page	What a particular patient is charged after clinical review
No separate membership fee	Yes	Published in all four product FAQs	Whether any checkout-specific fee appears later
$80 fee after approval if the patient declines	Yes	Published in all four product FAQs	How it is collected or disputed in practice
All 50 states	Yes	Repeated on product pages and homepage	State-by-state clinician coverage for every product on every date
Dr. Ana Lisa Carr supervises the program	Yes	Her NPI identity is independently findable in NPPES	Which clinician reviews a specific patient
HRT catalog is compounded	Yes	Every product sits in Josie’s compounded HRT catalog	Exact dispensed patch identity, manufacturer, NDC, strength, and pharmacy
“Cancel anytime”	Yes	Printed on product pages	The operational cancellation deadline and refund result
4.9/5 average rating	Yes	The number appears in Josie’s footer	Source, denominator, review method, and HRT-specific sample

What we actually did

• Read the current HRT category page and all four product pages.
• Recorded every published price, fee, plan inclusion, state claim, lab statement, and compounded disclosure.
• Read the current Terms of Service and Privacy Policy in full.
• Checked the named supervising physician’s NPI against the federal NPPES registry.
• Read the FDA’s February 20, 2026 warning letter to Join Josie on FDA.gov.
• Compared Josie’s current hormone-warning copy with the FDA’s 2025–2026 menopause-labeling actions.
• Checked the public review sample and compared testimonials appearing on Josie’s own pages.
• Re-verified the comparison-provider prices and policies used on this page.

What we did not do

• We did not enroll, receive a prescription, or receive medication.
• We did not see a checkout screen showing when the full three-month charge is collected.
• We did not see a dispensed pharmacy label.
• We did not test cancellation, a refund, the $80 fee, shipping time, or clinical response time.
• We did not independently audit every clinician’s license in all 50 states.

That limit matters. The strongest review is not the one that sounds certain about everything. It is the one that tells you exactly where certainty ends.

Is Josie Health legit?

Yes in the basic sense: Josie is an operating telehealth platform, publishes a named supervising physician, connects its NPI directly to the federal registry, and presents a live prescription-care process. “Legit” does not answer whether its particular medication model fits you. The material open questions are the pharmacy, exact strengths, patch identity, clinician assignment, and commercial terms.

What checks out

The supervising doctor is named and findable. Josie lists Ana Lisa Carr, MD, MBA as Supervising MD, publishes NPI 1689841744 and Tennessee license 53623, and describes her as a board-certified family-medicine physician with more than 15 years of experience and licensure in all 50 states. The federal NPPES registry independently confirms the name, NPI, and family-medicine taxonomy; Tennessee’s public system also returns her name with license 53623. The board-certification, experience, and all-state licensure claims remain provider-stated unless checked separately against every issuing body.^[6]

Credential detail	Status
Ana Lisa Carr, MD, MBA	Published by Josie
Supervising MD	Published by Josie
NPI 1689841744	Independently matched in the federal NPPES registry
Family medicine taxonomy	Independently matched in NPPES
Tennessee license 53623	Published by Josie and returned in Tennessee’s public system
Board-certified in family medicine	Provider-stated on Josie’s page
Licensed in all 50 states	Provider-stated; not independently audited state by state

Publishing a name and an NPI is more useful than the anonymous “board-certified providers” language common in telehealth. You can check the number yourself. That is a genuine strength.

The fit detail still matters. Dr. Carr’s published specialty is family medicine, and Josie emphasizes obesity medicine, metabolic health, and addiction-medicine training. That matches the company’s weight-care roots. Josie’s public provider directory profiles one clinician, while the patient-facing copy says a “licensed Josie provider” reviews each intake. We could not determine who reviews a given HRT case.

The compounded disclosure is clear. Every product page says compounded medications are not FDA-approved and that the FDA does not review them for safety, effectiveness, or quality before marketing. Josie also states that it does not manufacture the medications and that a licensed pharmacy or compounding pharmacy fills prescriptions when issued.^[1][2]

That deserves credit. Plenty of pages blur compounded medication into “basically the generic.” Josie’s current HRT pages do not.

What remains open

• The dispensing pharmacy is not named. FDA specifically warns that patients buying compounded drugs through online platforms may not know the identity of the compounder. For a compounded prescription, that identity is not trivia; it is the starting point for checking licensure, inspection history, and the label you will actually receive.^[7]
• No product strength is published. Not milligrams, percentages, grams per application, or patch release rate. You cannot compare dose, refill quantity, or equivalent retail options from the public page alone.
• The patch identity is unresolved. Josie places it under “Compounded Hormone Therapy Options” and labels the page “Compounded HRT · Transdermal,” but publishes no manufacturer, NDC, strength, or pharmacy.
• The legal pages call the company only “Josie.” The current Terms and Privacy Policy do not name a corporate entity, street address, governing law, or phone number.
• The 4.9/5 footer rating has no visible source or denominator. Treat it as a company-published number, not independent review evidence.

None of that proves the company is fake. It proves that “Is Josie real?” and “Do I have enough information to choose this medication model?” are different questions.

What does Josie HRT actually cost?

Josie publishes two three-month totals: $269 for the estradiol cream or estradiol patch, and $299 for either progesterone-plus-estradiol cream. The category page advertises “as low as $89/mo,” but the purchasable units shown on the product pages are three-month plans. Four consecutive plans equal $1,076 or $1,196 before any unlisted lab or outside cost.

The real published bill

Public product	Marketing equivalent	Published three-month total	Four consecutive plans
Estradiol body cream	About $90/month	$269	$1,076
Estradiol patch	About $90/month	$269	$1,076
Progesterone + estradiol body cream	About $100/month	$299	$1,196
Progesterone + estradiol vaginal cream	About $100/month	$299	$1,196

The category page’s “as low as $89/mo” is a monthly equivalent, not a separately published month-to-month HRT plan. The product pages display a three-month supply and total. We found no public HRT checkout terms showing a one-month option.^[1][2]

We are not calling that a trick. Quarterly bundles are common. But the number you should budget from the public page is $269 or $299, not $89.

What the published price includes

All four product pages list:

• Licensed-provider review of the intake
• Medication, if prescribed
• Unlimited messaging with the care team and provider
• Free shipping
• Provider-directed dose adjustments
• No separate membership fee

That is clean. Many telehealth programs stack a care fee on top of medication. Josie publishes one bundled three-month number.

The $80 fee almost nobody mentions

Every product FAQ says:

There is no upfront fee to complete the intake. An $80 consultation fee applies only if a licensed provider approves the care plan and the patient then chooses not to proceed with treatment.

That wording corrects a common misunderstanding. The fee is not published as a charge merely for submitting the intake. It attaches to the narrower approved-then-decline path.^[2]

The current pages do not publish:

• When the full $269 or $299 is charged
• What counts as “proceeding with treatment”
• Whether a patient can review the exact strength and pharmacy before the fee becomes applicable
• How a dispute or refund is handled

So ask before you submit: “At what exact step can I see the medication, strength, pharmacy, and total charge—and at what exact step can the $80 fee apply?”

Insurance, HSA, and FSA

Josie does not accept insurance. Its homepage says that directly. The HRT page says the company operates outside traditional insurance.^[3][4]

On HSA and FSA, Josie’s wording is appropriately limited: some patients use those accounts, but patients should confirm eligibility with their account provider. That is not a guarantee that your administrator will approve the expense.

Insurance is the thing that ends this for some of you

If the plan only works when insurance pays, Josie is not the answer. It does not bill insurance.

Midi says it is in-network with most PPO plans, with plan-specific deductibles, copays, and coinsurance. Its published self-pay rates are $250 for the first visit and $150 for follow-ups. Midi is out of network with Medicare, allows Medicare beneficiaries to self-pay without submitting Midi-related claims, and cannot treat Medicaid or Medi-Cal patients at this time.^[8]

Does insurance decide this for you? Check Midi’s current coverage rules and your plan.

This is an unpaid editorial link. We earn nothing from Midi through this link, nothing from Josie, and nothing if neither path fits.

What did the FDA warning letter to Join Josie say?

On February 20, 2026, the FDA sent Join Josie a warning letter about false or misleading marketing and label representations involving compounded semaglutide and tirzepatide. The letter concerned the weight-loss products named in it. It did not cite Josie’s hormone-therapy catalog, establish patient harm, order a recall, or evaluate whether Josie’s HRT works.

We are including the letter because omitting a verified regulatory action would be dishonest. We are limiting it because stretching a weight-loss marketing letter into a claim about hormone safety would also be dishonest.

What the FDA cited

FDA said it reviewed joinjosie.com in December 2025 and identified two main problems.^[9]

First: the pictured labels identified “Join Josie.” FDA said that presentation suggested Join Josie was the compounder when it was not.

Second: the site compared compounded products with FDA-approved Wegovy and Zepbound using “same active ingredient” claims. FDA said those statements implied the compounded products were FDA-approved or evaluated for safety and effectiveness when they were not.

FDA asked for a response within 15 working days and requested information identifying the entities producing the compounded products.

What the letter does not establish

The warning letter does not establish that:

• Josie’s HRT products were investigated or cited
• Any patient was harmed
• Every Josie prescription is unlawful
• The company ignored the letter
• The FDA evaluated the effectiveness of Josie’s hormone program
• The letter was a recall, civil judgment, or criminal finding

A warning letter is a serious regulatory notice. It is not permission to invent facts that are not in it.

You can see the current-site changes

This is one of the most useful original checks on this page: compare the language FDA cited with Josie’s current footer and HRT pages.

FDA’s February 2026 letter describes	Josie’s current site says
Labels suggested Join Josie was the compounder	“Josie is not a compounding pharmacy” and “Josie does not manufacture compounded medications”
“Same active ingredient” comparisons with FDA-approved brands	Current footer says compounded medications are not the same as FDA-approved generics
Claims implying approval or FDA evaluation	Current HRT pages say compounded medication is not FDA-approved and is not reviewed by FDA before marketing

That pattern reads like remediation. That is our inference from the before-and-after language, not an FDA conclusion. As of August 18, 2026, we found the warning letter but no public FDA close-out letter for it.

Why the letter still matters to an HRT buyer

It teaches the exact distinction you need here. FDA says compounded drugs are not FDA-approved and are not the same as FDA-approved generics. The agency does not verify a compounded product’s safety, effectiveness, or quality before marketing.^[7]

When any hormone company uses phrases like these, slow down:

• “Same active ingredient as the brand”
• “Basically the generic”
• “Just like an FDA-approved patch”
• “FDA-approved ingredients” as if that makes the finished compound approved
• “Clinically proven formula” without product-specific evidence
• “Safer because it is natural”

A finished compounded product and an FDA-approved finished product are different regulatory categories. That line does not move because the marketing sounds reassuring.

Is Josie’s HRT FDA-approved?

No. Josie presents all four public HRT options inside its compounded catalog and repeatedly says compounded HRT is not FDA-approved. FDA-approved estradiol and progesterone products also exist. The unresolved exception is not the rule—it is the exact identity of the patch Josie would dispense, because no manufacturer, NDC, strength, or pharmacy is published.

What compounded actually means

A compounded prescription can fill a real patient-specific need—for example, an allergy to an ingredient in available approved products or a dose or formulation that is not commercially available. FDA says compounded drugs are not FDA-approved, are not the same as generics, and do not receive premarket FDA verification of the finished product’s safety, effectiveness, or quality.^[7]

Federal law contains different pathways for patient-specific compounding under section 503A and outsourcing facilities under section 503B. Oversight differs by setting. “Not FDA-approved” does not mean “no law applies.” It means the finished compounded product has not gone through FDA’s approval process.

Question	FDA-approved drug	Compounded drug
FDA reviews the finished product before marketing	Yes	No
FDA-approved prescribing information	Yes	No FDA-approved label for the compound
Therapeutic equivalence as a generic	Can be established through FDA approval	No
Patient-specific formulation flexibility	Limited to approved presentations	Can be a legitimate reason to compound
Appropriate to call it “the same as” an approved product	—	No

The Menopause Society’s 2022 position statement makes a second distinction many marketing pages erase: FDA-approved “bioidentical” estradiol and micronized progesterone already exist. “Bioidentical” does not automatically mean compounded. The statement says compounded hormone therapy should generally be considered when an approved product cannot meet a specific need—not because “compounded” sounds more natural or premium.^[10]

Is Josie’s estradiol patch actually compounded?

This is the question the public site does not resolve.

Josie’s patch page:

• Carries the label “Compounded HRT · Transdermal”
• Sits inside “Compounded Hormone Therapy Options”
• Says the plan includes compounded hormone therapy shipped from a licensed pharmacy
• Does not publish the manufacturer, NDC, strength, or dispensing pharmacy

We will not call the dispensed patch FDA-approved. We will not claim to have seen a compounded patch. We have not seen the label.

Ask this exact question before paying:

“Is the estradiol patch you would dispense an FDA-approved manufactured patch? If yes, what is the manufacturer, product name, strength, and NDC? If not, which pharmacy compounds it, and what exact formulation and release rate will appear on my label?”

A clear answer settles the issue. Anything else is fog.

Josie’s hormone-warning copy has not caught up with FDA’s label changes

All four current product pages reproduce older class-warning language about “probable dementia.” The systemic pages also say to use the “lowest effective dose for the shortest time.”^[2]

In November 2025, FDA requested that approved menopausal hormone-therapy manufacturers remove cardiovascular disease, breast cancer, and probable-dementia language from boxed warnings for systemic and local vaginal products; remove the “lowest effective dose for the shortest amount of time” recommendation from boxed warnings; and retain the endometrial-cancer boxed warning for systemic estrogen-alone products. FDA’s public tracker listed the first updated products in February 2026, including Prometrium, Estring, and Bijuva.^[11][12]

Two things are true at once:

1. Josie is voluntarily publishing prominent risk information for compounded products that do not have an FDA-approved label.
2. Its current copy still reproduces language FDA instructed approved-product manufacturers to remove or reposition.

The precise criticism is not that FDA ordered Josie to relabel a compounded product. The precise criticism is that Josie’s patient-facing safety copy is using an older framing after FDA publicly changed the framing for approved menopausal hormone therapy.

That is especially important on the vaginal product. FDA-approved low-dose vaginal estrogen has a different evidence base and exposure profile from systemic therapy. Josie’s product is a compounded estradiol-plus-progesterone vaginal cream with no public strength, so you cannot assume the evidence for an approved low-dose vaginal product automatically transfers to it.

Read what the FDA’s hormone-label changes actually mean before old warning language scares you away from every form of treatment—or reassures you about a product that has not published its dose.

Do you need progesterone with Josie if you still have a uterus?

If you have a uterus and use systemic estrogen, you need adequate endometrial protection. Josie’s public catalog contains no standalone oral progesterone and markets one compounded transdermal progesterone-plus-estradiol cream for uterine-lining protection. Current menopause guidance says transdermal micronized progesterone has variable absorption and is unlikely to provide sufficient protection. That is Josie’s biggest medication-fit problem.

This is the most important section on the page.

Why the uterus question changes the verdict

Unopposed systemic estrogen increases endometrial-cancer risk in a woman with an intact uterus. The Menopause Society says adequate concomitant progestogen is recommended when systemic estrogen is used.^[10]

After a total hysterectomy, estrogen-only treatment is often the simpler path because there is no endometrium to protect. A subtotal hysterectomy, residual endometrial tissue, endometriosis history, or another individual factor can change that plan. Your clinician—not a quiz and not this page—has to establish what surgery you had and what protection you need.

What Josie publishes for each route

Public Josie product	Intended scope on Josie’s page	Public uterus issue
Estradiol body cream	Systemic symptoms	Estrogen only; Josie says progesterone is usually paired if the uterus is intact
Estradiol patch	Systemic symptoms	Estrogen only; page says progesterone is usually prescribed alongside it
Progesterone + estradiol body cream	Systemic symptoms	Marketed by Josie as uterine-lining protection; progesterone is transdermal
Progesterone + estradiol vaginal cream	Local vaginal/urinary symptoms	Not published as the companion-progestogen plan for systemic estrogen; strength is not shown
Standalone oral micronized progesterone	—	Not present in the public catalog

The public patch page creates an obvious unanswered question: it says progesterone is usually prescribed alongside the patch, but the public catalog does not show a standalone progesterone product. Josie may have a clinician-directed path that is not visible on the marketing site. The site does not tell you what it is.

What current guidance says about progesterone through the skin

The British Menopause Society’s May 2026 clinician tool is direct: micronized progesterone has variable transdermal absorption and is unlikely to provide sufficient estrogen opposition. It cites the 2016 Stute systematic review and says micronized progesterone within HRT regimens should not be administered transdermally because it is unlikely to provide sufficient endometrial protection.^[13][14]

That does not prove we know Josie’s hidden dose, pharmacy technique, or monitoring protocol. Josie does not publish them. It does mean the burden is on the plan to answer a serious route-of-delivery problem with something more specific than “the cream contains progesterone.”

What this does—and does not—mean

It does not mean every Josie clinician is careless. A provider could decline systemic estrogen, recommend a different plan, coordinate with another prescriber, or require monitoring we cannot see.

It does mean this:

If you have a uterus and want systemic estrogen, Josie’s public catalog does not show a guideline-supported, predictably absorbed standalone progestogen option.

That is a reasonable reason to start elsewhere unless the treating clinician gives you a documented plan that resolves it.

What a clearer protection pathway looks like

Common clinician-directed options include:

• An FDA-approved oral micronized progesterone capsule used in an evidence-based regimen
• Another established progestogen regimen selected for the estrogen dose
• A clinician-managed levonorgestrel intrauterine system when appropriate

The specific dose and schedule are prescription decisions. The point is not “every woman needs the same capsule.” The point is that the protection route and dose must be adequate for the estrogen exposure.

The question to send before you pay

“I still have my uterus. If systemic estrogen is proposed, what exact medication, route, dose, and schedule will protect my endometrium? If you plan to use transdermal progesterone, what evidence supports that formulation and what is the monitoring plan for bleeding or endometrial change?”

A real answer names the product and dose, explains why it is adequate, and tells you what happens if bleeding occurs.

A vague answer says: “It has progesterone, and progesterone protects the uterus.” That is the sales sentence. It is not the plan.

You are allowed to wait for the plan.

If this is your situation, here is the honest next step

Uterus intact, disruptive hot flashes or night sweats, and systemic estrogen is what you are exploring? Then the decision is no longer about which cream looks convenient. It is about whether the program can provide a clear estrogen-plus-endometrial-protection pathway.

Winona’s public catalog lists an FDA-approved estradiol patch from $149 per 28-day billing cycle and FDA-approved progesterone capsules from $39 per 28-day cycle. Winona treats women ages 35–59 in 37 states plus Puerto Rico, so it is not available to everyone.^{[15][16][17][18]}

Does that match what you need? See Winona’s current patch and progesterone options (sponsored).

We may earn a commission if you start care with Winona. We earn nothing from Josie. The higher Winona cost is not hidden; it is the next section.

Is Winona more expensive than Josie? More than twice as much

The Winona patch-plus-capsule route we just mentioned costs more than twice Josie’s lowest public three-month plan at current starting prices. A $149 patch plus $39 progesterone capsule billed every 28 days is about $2,451 a year. Four $269 Josie plans equal $1,076. The difference is about $1,375—and we are not going to dress it up.

Current-price scenario	Billing unit	Approximate annual total
Josie $269 plan, repeated four times	Three months	$1,076
Josie $299 plan, repeated four times	Three months	$1,196
Winona patch from $149 + capsule from $39	Every 28 days	About $2,451

The Winona number is a starting-price scenario, not a promise of every patient’s bill. Winona says plan totals vary and 30-day prescriptions process every 28 days. The calculation is $188 × 365 ÷ 28.^[15][16][17]

What the extra money buys

For the right reader, it buys two public details Josie does not currently give you:

• A patch Winona identifies as FDA-approved
• A standalone progesterone capsule Winona identifies as FDA-approved

That is not worth $1,375 to everyone.

If you have had a total hysterectomy, do not need progestogen for another reason, deliberately prefer compounded care, and receive a clear answer on the actual product and pharmacy, Josie can be the cheaper fit. We would rather you keep $1,375 than pay for a feature you do not need.

Cheaper routes that do not require pretending the difference is small

• Midi through insurance: Often the best economic path when a PPO covers the visits and your prescription benefit covers approved medication.
• Sesame: A cash-pay menopause subscription with video care, messaging, included basic labs when ordered in most states, and prescriptions sent to your preferred pharmacy; medication costs are separate.^[19]
• Winona with an outside pharmacy: Winona publishes a $50 monthly platform fee when a prescription is sent to an outside pharmacy, plus the pharmacy cost. Confirm the exact prescription and pharmacy price first.^[20]
• Your existing clinician: Take the question list from this page to the appointment. It can be the cheapest route when you can get the care you need.

Because “just spend more” is not advice.

Where Josie genuinely wins

Access. Josie says all 50 states. Winona’s current state page lists 37 states plus Puerto Rico.^[4][18]

Published age floor. Josie’s Terms require users to be at least 18 and the HRT pages publish no upper age cutoff. Winona says its HRT program treats women 35–59.^[5][17]

That does not mean every 18-year-old or every older woman is clinically eligible for Josie HRT. It means Josie does not publish Winona’s age gate. Provider review still decides.

If another program has already rejected you for age or state, see which online HRT models may still serve your situation.

What are Josie’s four hormone products?

Josie publishes four compounded HRT options: an estradiol body cream, an estradiol patch, a progesterone-plus-estradiol body cream, and a progesterone-plus-estradiol vaginal cream. Prices are $269 or $299 per three-month plan. The pages publish routes and broad symptom targets, but no strength, concentration, patch release rate, pharmacy, or standardized label.

Product	Route	Published price	Public symptom scope	Public strength	Public FDA status
Estradiol cream	Skin/body	$269 / 3 months	Hot flashes, night sweats, systemic symptoms	Not published	Presented as compounded; not FDA-approved
Estradiol patch	Skin/patch	$269 / 3 months	Hot flashes, night sweats, systemic symptoms	Not published	Catalog labels it compounded; exact dispensed identity unresolved
Progesterone + estradiol body cream	Skin/body	$299 / 3 months	Systemic symptoms plus claimed uterine-lining protection	Not published	Compounded; not FDA-approved
Progesterone + estradiol vaginal cream	Vaginal/local	$299 / 3 months	Dryness, irritation, painful sex, urinary symptoms	Not published	Compounded; not FDA-approved

Estradiol cream — $269 for three months

Josie describes a compounded estradiol cream applied to the skin for whole-body symptoms.

A 2023 observational study compared estrogen exposure in women using compounded transdermal estradiol creams with women using FDA-approved patches or gels. At comparable nominal doses, the compounded-cream group had lower measured estrogen exposure. That does not prove every cream fails. It does prove that “cream” and “patch” should not be treated as dose-for-dose interchangeable without product-specific data.^[21]

Not for you if: You have a uterus and no adequate progestogen plan has been established.

Estradiol patch — $269 for three months

Josie describes a patch worn on the skin and changed on a provider-directed schedule.

The problem is not that patches are bad. FDA-approved estradiol patches are a standard route. The problem is that this public page does not identify the patch.

Before paying: Ask for the manufacturer, product name, NDC, strength, change schedule, and pharmacy.

Progesterone + estradiol body cream — $299 for three months

Josie markets this compounded transdermal combination for systemic symptom relief and uterine-lining protection.

This is the product at the center of the endometrial-protection concern. The public page provides no milligram strength for either hormone and no monitoring protocol. Read the uterus section above before treating “contains progesterone” as the end of the question.

Progesterone + estradiol vaginal cream — $299 for three months

Josie markets this compounded local cream for vaginal dryness, irritation, discomfort during sex, and urinary symptoms.

Two facts should slow you down:

1. The public page provides no estradiol or progesterone strength.
2. The Menopause Society’s low-dose-vaginal-estrogen guidance applies to low-dose vaginal estrogen products, not automatically to an unidentified compounded estradiol-plus-progesterone combination.

For women whose only problem is genitourinary syndrome of menopause, The Menopause Society says low-dose vaginal estrogen is generally preferred over systemic therapy and generally does not require a progestogen at recommended low doses, although postmenopausal bleeding still requires evaluation.^[10]

That does not tell us Josie’s unknown dose. It tells you what to compare it against.

If vaginal dryness or painful sex is your only major symptom, start with our vaginal estrogen guide before spending $299 on a product whose strength is not public.

What Josie does not publish in its HRT catalog

• Standalone oral progesterone
• Oral estrogen
• Testosterone
• A clearly identified FDA-approved product
• Published strengths for any of the four options
• A named dispensing pharmacy
• A published nonhormonal hot-flash medication pathway

FDA-approved nonhormonal options exist for some women who cannot or do not want to use hormones. See the current nonhormonal options.

What happens when you sign up for Josie?

Josie says there is no upfront fee to complete the intake. You submit an online health history, a licensed provider reviews it, the care team may follow up by message, and medication is shipped from a licensed pharmacy if prescribed. Most patients hear from a provider within 24–48 hours, according to Josie. The site does not publish the exact moment the full plan charge occurs.

The verified public flow

1. Choose the HRT path or product you want to explore.
2. Complete the online intake with symptoms, health history, goals, and state.
3. A licensed Josie provider reviews the information.
4. The care team may ask follow-up questions by message.
5. If clinically appropriate, a prescription and care plan are issued.
6. Medication is shipped by a licensed pharmacy or compounding pharmacy.
7. Ongoing questions and provider-directed adjustments happen through messaging.

Josie’s HRT page says no commitment is required to complete the intake, and the product pages say there is no upfront intake fee. The public pages do not establish whether the full three-month plan is charged before or after the exact medication details are shown.^[1][2]

That is why the pre-pay questions on this page matter.

Do you need labs?

Not as a standard published requirement. Josie says lab work may be recommended depending on the health history and provider review.^[1]

That can be clinically reasonable. Menopause is often diagnosed from age, symptoms, menstrual history, and clinical context rather than a single hormone level. But testing may still be needed when symptoms, bleeding, thyroid disease, anemia, pregnancy possibility, or another condition changes the picture.

Josie does not publish the price of any lab work. Ask whether a recommended test is included, where it is performed, and who bills it.

What “approved” does not guarantee

An approved care plan does not tell you, from the public site alone:

• Which clinician reviewed the case
• Which pharmacy will fill the prescription
• The exact strength
• Whether the patch is a manufactured FDA-approved product or something else
• When the full charge becomes nonrefundable
• How quickly a clinical question will be answered

Get those facts before the word “approved” makes you feel more informed than you are.

If you have read all of that and Josie still fits

Cash-pay. Compounded therapy chosen on purpose. No insurance dependence. A clear answer to the uterus question. Comfortable with an intake-and-messaging model. Willing to verify the pharmacy, strength, and commercial terms before accepting the plan.

That is a real person. Josie can be a reasonable option for her.

Open Josie’s HRT intake — take the checklist below with you.

This link is unpaid. The HRT Index receives no commission from Josie.

What do real Josie customers say?

The independent review record is too small to support a confident care-quality conclusion. Trustpilot showed a 3.8 score from five reviews on August 18, 2026. Most reviews discussed GLP-1 care or mixed services, not HRT alone. Josie’s own site displays 4.9/5 without a visible source or review count, so we do not use it as an independent rating.

The review sample, without pretending five is five thousand

Trustpilot’s five-review sample included:^[22]

• One reviewer who had used Josie for more than a year, reached a GLP-1 weight goal, moved to microdose maintenance, and then added HRT. She described the service as simple and responsive.
• One reviewer who described fast approval and shipping and said Josie did not auto-bill her; that is one customer’s account, not a binding policy.
• One reviewer who praised the product but said two medical questions went unanswered. Josie replied that clinical follow-up should have been timelier.
• One one-star reviewer who said billing support was reachable but medical personnel did not return calls or portal messages. Josie said it could not verify the account without identifying information.

These are individual experiences. They cannot establish whether a medication is safe, effective, correctly dosed, or appropriate for you.

The 4.9/5 with no denominator

Josie’s footer displays “Average Rating 4.9/5” across the site. We found no visible review count, source, methodology, or link attached to that number.^[1]

It may be based on a real internal dataset. The page does not let you inspect it. We will not convert it into review schema, an aggregate rating, or a quality conclusion.

The testimonials on Josie’s own pages need context

Josie’s homepage and HRT page label named testimonials as verified clients. The same names—including Sarah M., Amanda K., and Lisa P.—appear across the pages with different stories. On the HRT page, multiple testimonials say Dr. Carr personally reviewed the case, while the rest of the site says a licensed Josie provider performs the review.^[1][3]

We cannot determine from public pages whether these are different experiences from the same people, edited composites, or another arrangement. We also cannot independently verify the patients.

That is the honest conclusion: the testimonials may be genuine, but the public evidence is not strong enough for us to use them as proof of HRT outcomes or care consistency.

Can you cancel Josie, and can you get a refund?

Josie’s product pages say “cancel anytime,” but the Terms of Service dated January 15, 2026 contain no cancellation procedure, refund policy, subscription schedule, auto-renewal language, or description of the $80 approved-then-decline fee. Get the deadline, renewal mechanics, and refund treatment in writing before accepting a plan.

We read the full Terms. They contain nine short sections covering platform use, telehealth services, eligibility, prescriptions, payments, liability, and modifications.^[5]

Current product-page statement	Current Terms of Service
“Cancel anytime”	No cancellation procedure or deadline
Three-month plan	No renewal or auto-renewal schedule
$80 fee after approval if patient declines	Not mentioned
No upfront intake fee	Not mentioned
Medication ships if prescribed	Terms say prescriptions may be fulfilled by licensed pharmacies
$269–$299 published totals	Terms say users agree to pay fees, without listing the HRT totals
Refund result	No refund clause

The absence of a clause does not prove Josie refuses refunds. It means the public Terms do not give you a rule you can rely on.

The Privacy Policy has a smaller but revealing gap

The current Privacy Policy says Josie may collect health history, symptoms, prescription information, payment information, intake responses, and device data. It says information may be shared with healthcare providers, pharmacies, technology vendors, payment processors, customer-support providers, legal authorities, and a buyer in a merger or asset sale.^[23]

Its privacy-rights section tells users to contact Josie “using the information below.” The policy itself provides no contact details below that sentence before the site footer. Josie does have a separate contact page and publishes team@joinjosie.com elsewhere, but the policy does not complete its own instruction.

Send this before you accept the plan

“Please confirm in writing: (1) when the full three-month charge occurs, (2) whether the plan renews automatically, (3) the cancellation deadline, (4) the refund rule before and after the pharmacy prepares or ships medication, and (5) exactly what action triggers the $80 consultation fee.”

If the answer is clear, you have something useful. If it is vague, that is useful too.

Who should not use Josie?

Josie is not the right starting point when the public catalog cannot show a medication pathway that fits the clinical or financial constraint. The fastest disqualifiers are an intact uterus plus systemic estrogen, an FDA-approved-only preference, insurance dependence, unexplained bleeding, or unwillingness to accept an unnamed pharmacy and unpublished strength.

If this is you	Why Josie may not fit	Better next step
You have a uterus and want systemic estrogen	No public standalone oral progesterone; published protective option is transdermal compounded progesterone	Winona’s FDA-approved patch + capsule pathway, Midi, Sesame, or your clinician
You want only FDA-approved medication	Public Josie HRT catalog is presented as compounded	Midi, Sesame, or another retail-pharmacy model
Insurance must pay	Josie does not accept insurance	Check Midi and your exact PPO benefits
You have Medicaid or Medi-Cal	Josie is cash-pay; Midi cannot treat these patients either	Start with your plan directory or local clinician
You have Medicare	Josie is cash-pay; Midi accepts Medicare beneficiaries only as self-pay without Midi-related claims	Compare local Medicare-participating clinicians and prescription coverage
Vaginal dryness or painful sex is your only major symptom	Josie’s $299 compounded combination has no public strength	Compare FDA-approved low-dose local options in our vaginal estrogen guide
You want the pharmacy named before intake	Josie does not name it publicly	Use a provider that sends a prescription to your chosen pharmacy or discloses the compounder
You want standard labs included	Josie says labs may be recommended, with no published cost	Sesame includes listed basic labs when ordered in most states; Midi can order appropriate testing
You have unexplained vaginal bleeding	Josie’s own pages list this as not appropriate; bleeding can require examination and workup	See a clinician before starting online HRT
You have a complex cancer, clot, stroke, liver, or pregnancy history	Josie’s pages list several of these histories as exclusions	Start with a clinician equipped for the necessary risk review and coordination
You need a guaranteed video visit	Josie publishes an intake-and-message model, not a promised video appointment	Midi or Sesame
You need refund rules before paying	Current Terms do not contain them	Get written terms first or choose a provider with published cancellation rules

If two or more rows describe you, stop trying to make Josie fit. The answer is a different starting point, not a more persuasive landing page.

Find My HRT Path — it uses the exact decision points in this table and flags when online care should not be the starting point.

Josie vs. Winona, Midi, and Sesame

Josie’s strongest advantages are a low bundled three-month price, all-50-state provider-stated access, and no published upper age cutoff. Its biggest disadvantages are an all-compounded public catalog, no published standalone oral progesterone, no insurance billing, no named pharmacy, and no public strengths. The alternative that wins depends on the constraint that ends the decision.

Provider	Care model	Medication model	Public oral progesterone	Current published care price	Insurance	Labs	Key access limit
Josie	Online intake + messaging	Four public HRT options presented as compounded	None in public catalog	$269–$299 / 3 months, medication included if prescribed	No	May be recommended; cost not published	Says all 50 states; minimum platform age 18
Winona	Asynchronous intake + portal messaging	FDA-approved patch/capsule plus compounded products	Yes; capsule from $39	Patch from $149 + capsule from $39 per 28-day cycle	No	Not routinely required	Ages 35–59; 37 states + Puerto Rico
Midi	Scheduled virtual visits	Says it prescribes FDA-approved bioidentical hormones; pharmacy costs separate	Yes, when clinically appropriate	$250 first self-pay visit; $150 follow-ups	In-network with most PPO plans; restrictions for Medicare/Medicaid	Clinician-directed	Coverage and state availability must be checked
Sesame	Video visit + messaging subscription	Prescriptions sent to preferred pharmacy; lists estradiol, progesterone, combined and nonhormonal options	Yes	Subscription price shown at checkout; medication separate	Does not bill insurance for care; medication/labs may be covered by plan	Listed basic labs included when ordered, with state exceptions	Provider and pharmacy availability vary

Choose Josie if you understand the compounded model, its public medication route fits, the pharmacy and strength answers satisfy you, and the all-50-state reach or lack of an upper age cutoff solves an access problem.

Choose Winona if you are 35–59 in a served jurisdiction and want a publicly identified FDA-approved patch and oral progesterone capsule shipped through one asynchronous program—and the higher price works.

Choose Midi if insurance is the economic lever, you want scheduled clinician visits, or you want a broader midlife-care workup with FDA-approved prescriptions.

Choose Sesame if you want a video visit, a broad published medication menu, basic labs when ordered, and a prescription sent to a pharmacy rather than an unidentified bundled compound.

Choose your own clinician if you can get the appointment and the relationship already works. Take the question list below.

What should you verify before paying Josie?

Get the medication identity, strength, route, pharmacy, FDA status, charge timing, renewal rule, lab cost, response channel, and cancellation terms in writing. If you have a uterus and systemic estrogen is proposed, add the exact progestogen route, dose, schedule, evidence, and bleeding-monitoring plan. The checklist is the product this review should leave in your hands.

The Josie pre-pay checklist

About the medication

• [ ] Exact medication and ingredient names
• [ ] Exact strength or concentration of every hormone
• [ ] Exact amount applied or delivered per dose
• [ ] Route: body cream, patch, or vaginal
• [ ] Compounded or FDA-approved finished product
• [ ] If manufactured: product name, manufacturer, and NDC
• [ ] If compounded: pharmacy name, location, and state license
• [ ] Whether the pharmacy is a 503A pharmacy or 503B outsourcing facility
• [ ] Quantity supplied for the full three months
• [ ] Refill and dose-adjustment process

About the uterus question

• [ ] Whether the clinician has confirmed that your uterus is intact, absent, or partially retained
• [ ] Exact endometrial-protection medication, route, dose, and schedule
• [ ] Why that route is adequate for the estrogen dose
• [ ] What bleeding requires a message, urgent visit, ultrasound, biopsy, or in-person evaluation
• [ ] What monitoring is planned over time

About the money

• [ ] Exact total charged today
• [ ] Exact step when the charge occurs
• [ ] Exact step when the $80 fee can apply
• [ ] Whether the plan auto-renews
• [ ] Next billing date and amount
• [ ] Cancellation deadline and method
• [ ] Refund treatment before preparation, after preparation, and after shipment
• [ ] Lab location and out-of-pocket cost

About the care

• [ ] Treating clinician’s name and license state
• [ ] Expected clinical-response time
• [ ] How urgent symptoms are handled
• [ ] Whether a video or phone visit is available when messaging is not enough
• [ ] What happens when online care is not sufficient

A company that answers all of that clearly has earned more trust. A company that dodges three of them has answered you anyway.

Our verdict on Josie

Josie earns a conditional fit verdict, not a blanket recommendation. It is a real telehealth platform with clear bundled prices, a named clinical supervisor, broad provider-stated access, and honest compounded disclosures. It may be a reasonable lower-cost choice after hysterectomy or when compounded treatment is chosen deliberately. It is not our starting pick for an intact-uterus systemic-estrogen plan.

Here is how it lands under The HRT Index Verification Standard, without a fake numeric score.

Clinical legitimacy

Strong enough to establish a real operating clinical pathway: a named supervising physician, public NPI, telehealth intake, prescription requirement, and pharmacy fulfillment when prescribed.

The limits: one public clinician profile, no way to know who reviews a specific case, no independently completed all-state license audit, and a February 2026 FDA warning letter concerning weight-loss marketing. The warning letter is company history; it is not an HRT finding.

Care quality

Unlimited messaging and provider-directed adjustments are good published features. Josie says most patients hear back within 24–48 hours.

Independent evidence is too thin to declare consistent quality. Five Trustpilot reviews cannot carry that conclusion, and the clearest negative review theme was unanswered clinical communication—the exact thing “unlimited messaging” is supposed to solve.

Medication fit

This is the weakest pillar.

Four products sound like breadth until you see what is missing: no public strength, no named pharmacy, no clearly identified FDA-approved product, no standalone oral progesterone, and an unresolved patch identity. For a woman with an intact uterus seeking systemic estrogen, the transdermal-progesterone evidence problem is material.

Price transparency

Strong on the front number: $269 or $299 for three months, medication and support included, no separate membership fee.

Weaker underneath: “as low as $89/mo” is a monthly equivalent rather than a public month-to-month plan; the $80 fee lives in product FAQs; and the Terms contain no renewal, cancellation, or refund procedure.

Access

Provider-stated availability in all 50 states and no published HRT upper age cutoff are real competitive advantages. The asynchronous model can also be easier than waiting months for a local appointment.

The limits are no insurance billing, no promised video visit, unknown pharmacy, and clinical eligibility that still depends on the provider review.

The one-sentence verdict

Josie is cheaper and more geographically open than several menopause telehealth programs, but its public HRT catalog asks you to accept more medication uncertainty—especially if you still have a uterus.

We do not score that with a number. A number would hide the deciding fact.

Frequently asked questions

Is Josie Health the same as Join Josie?

Yes for this search intent. The company calls itself Josie or Join Josie and operates at joinjosie.com. It is not Josi Health, the separate autism and ADHD evaluation company.

Is Josie Health legit?

Josie is an operating telehealth platform with a named supervising physician and a public NPI that matches the federal registry. Its public HRT options are presented as compounded. The main unresolved issues are the exact pharmacy, strengths, patch identity, clinician assignment, and commercial terms—not whether the site exists.

How much does Josie HRT cost?

The estradiol cream and patch are $269 per three-month plan. The progesterone-plus-estradiol body cream and vaginal cream are $299 per three-month plan. Four consecutive plans equal $1,076 or $1,196. No separate membership fee is published.

Is there a monthly Josie HRT plan?

The HRT category advertises “as low as $89/mo,” and product pages show about $90 or $100 per month, but the public product unit is a three-month plan costing $269 or $299. We found no separately published month-to-month HRT plan.

Is Josie’s HRT FDA-approved?

No. Josie presents the public HRT catalog as compounded and says compounded medication is not FDA-approved. The patch page does not publish enough information to identify the dispensed product, so ask for the manufacturer, NDC, strength, and pharmacy.

Does Josie take insurance?

No. Josie says it does not accept insurance. It says some patients use HSA or FSA accounts but tells patients to confirm eligibility with their account provider.

What states is Josie available in?

Josie says all 50 states. We did not independently verify every clinician-product-state combination, so confirm availability for your state and intended plan during intake.

Does Josie require blood work?

Not as a standard public requirement. Josie says lab work may be recommended depending on the health history and provider review. Any lab cost is not published.

Does Josie prescribe progesterone?

Its public catalog contains progesterone only inside two compounded combination creams that also contain estradiol. It does not publish a standalone oral progesterone product.

Do I need progesterone with Josie’s estradiol?

If you have an intact uterus and use systemic estrogen, you need adequate endometrial protection. Josie’s public systemic combination uses transdermal progesterone, a route current guidance says has variable absorption and is unlikely to provide sufficient protection. Get the exact product, dose, evidence, and monitoring plan before accepting treatment.

Which pharmacy does Josie use?

Josie says prescriptions are filled by a licensed pharmacy or compounding pharmacy but does not publicly name the pharmacy. Ask for the pharmacy name and license before accepting a compounded prescription.

Who is the doctor behind Josie?

Josie lists Ana Lisa Carr, MD, MBA as Supervising MD, publishes NPI 1689841744 and Tennessee license 53623, and says she is board-certified in family medicine and licensed in all 50 states. The NPI identity is independently verifiable; the broader claims are provider-stated unless checked with each credentialing body.

When does Josie charge you?

Josie says there is no upfront fee to complete the intake and that an $80 fee applies only if a provider approves the plan and the patient then declines. The public pages do not state the exact point when the full $269 or $299 charge occurs. Ask before submitting.

Can you cancel Josie and get a refund?

Product pages say “cancel anytime,” but the current Terms of Service contain no cancellation process, refund rule, renewal schedule, or auto-renewal language. Get those terms in writing before accepting the plan.

What was the FDA warning letter about?

The February 20, 2026 warning letter concerned false or misleading marketing and pictured-label representations for compounded semaglutide and tirzepatide. It did not cite Josie’s HRT products. We found no public FDA close-out letter as of August 18, 2026.

Is Josie better than Winona?

Neither wins for everyone. Josie is much cheaper in the compared scenario, says it serves all 50 states, and publishes no upper age cutoff. Winona publicly identifies an FDA-approved patch and oral progesterone capsule, but treats ages 35–59 in 37 states plus Puerto Rico and costs more.

Is Josie better than Midi?

Josie may fit better when you are cash-pay, want a bundled medication price, and deliberately choose compounded care. Midi is usually the stronger path when PPO insurance matters, you want scheduled virtual visits, or you want FDA-approved prescriptions and broader testing coordination.

Is Josie better than Sesame?

Josie bundles medication with the three-month plan and uses an asynchronous intake model. Sesame uses video visits, lists a broader medication menu, includes specified basic labs when ordered in most states, and sends prescriptions to a preferred pharmacy; medication is priced separately.

How we produced this review

Why this page exists. Most public reviews of Join Josie focus on GLP-1 weight care. That does not answer the woman staring at a $269 hormone plan and wondering what is compounded, what protects her uterus, what the FDA letter means, or what she will be charged if she changes her mind.

How we checked. The HRT Index Verification Standard requires us to read every published price, keep FDA-approved and compounded medication separate, verify state and insurance claims where possible, and re-check top providers monthly and the full roster quarterly. We checked Josie’s live product, category, homepage, provider, Terms, and Privacy pages on August 18, 2026. Medical and regulatory conclusions are tied to FDA materials, The Menopause Society, the British Menopause Society, and peer-reviewed literature.

What remains unresolved. The exact patch identity. Every product strength. The dispensing pharmacy. The charge point for the full three-month plan. The practical cancellation and refund result. The clinician assigned to a particular patient. Whether FDA has privately accepted Josie’s response or will later issue a public close-out letter.

What we earn. Nothing from Josie. Links to Josie are unpaid. The Midi link on this page is also unpaid. We may earn a commission from Winona when a qualifying sponsored link is used. That relationship does not change the verdict, and the sponsored link is labeled. Read our full affiliate disclosure.

Found something wrong? Email partners@thehrtindex.com or see our corrections policy.

Revision log

Date	Change
August 18, 2026	First publication. Verified the HRT catalog, prices, fees, provider identity, insurance, labs, state claim, Terms, Privacy Policy, review sample, FDA warning letter, FDA hormone-label changes, and comparison-provider facts.

---

Still not sure which HRT program is right for you? Take our free 90-second matching quiz.

Find My HRT Path asks about your symptoms, state, uterus status, medication preference, risk history, and insurance—then shows which provider models fit and when online care is not the right starting point.

---

This page is educational and is not medical advice. It was not medically reviewed by a clinician. Hormone-therapy decisions belong with a licensed clinician who knows your history.

Sources

¹ Join Josie, “Hormone Replacement Therapy (HRT) for Perimenopause & Menopause,” including its four-product catalog, labs, insurance, testimonials, and intake language. Verified August 18, 2026. https://www.joinjosie.com/category/hrt

² Join Josie product pages, verified August 18, 2026: Estradiol Cream (https://www.joinjosie.com/category/hrt/estradiol-cream); Progesterone + Estradiol Body Cream (https://www.joinjosie.com/category/hrt/progesterone-estradiol-cream); Estradiol Patch (https://www.joinjosie.com/category/hrt/estradiol-patch); Progesterone + Estradiol Vaginal Cream (https://www.joinjosie.com/category/hrt/estradiol-vaginal-cream).

³ Join Josie homepage, including insurance, states, response-time, care-flow, rating, and testimonial language. Verified August 18, 2026. https://www.joinjosie.com/

⁴ Join Josie homepage and HRT pages, provider-stated all-50-state availability and cash-pay model. https://www.joinjosie.com/ and https://www.joinjosie.com/category/hrt

⁵ Join Josie, “Terms of Service,” last updated January 15, 2026. https://www.joinjosie.com/legal/terms-of-service

⁶ Join Josie, Ana Lisa Carr provider page; CMS NPPES NPI Registry, provider 1689841744; Tennessee public health-system result for Ana Lisa Carr, license 53623. https://www.joinjosie.com/providers/ana-lisa-carr; https://npiregistry.cms.hhs.gov/provider-view/1689841744; https://internet.health.tn.gov/VRISMUserAgreement/UserAgreement/UserAgreement

⁷ U.S. Food and Drug Administration, “Compounding and the FDA: Questions and Answers,” updated September 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

⁸ Midi Health, “Pricing & Insurance” and HRT pages, verified August 18, 2026. https://www.joinmidi.com/pricing-insurance and https://www.joinmidi.com/hrt

⁹ U.S. Food and Drug Administration, “Join Josie MARCS-CMS 717986,” warning letter dated February 20, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/join-josie-717986-02202026

¹⁰ The North American Menopause Society, “The 2022 Hormone Therapy Position Statement of The North American Menopause Society,” Menopause. https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf

¹¹ U.S. Food and Drug Administration, “FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies,” November 10, 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requests-labeling-changes-related-safety-information-clarify-benefitrisk-considerations

¹² U.S. Food and Drug Administration, “Menopausal Hormone Therapies with Updated Prescribing Information,” February 12, 2026. https://www.fda.gov/drugs/drug-safety-and-availability/menopausal-hormone-therapies-updated-prescribing-information

¹³ British Menopause Society, “Progestogens and endometrial protection,” Tool for Clinicians, May 2026. https://thebms.org.uk/wp-content/uploads/2026/05/14-NEW-BMS-TfC-Progestogens-and-endometrial-protection-MAY2026-A.pdf

¹⁴ Stute P, Neulen J, Wildt L. “The impact of micronized progesterone on the endometrium: a systematic review.” Climacteric. 2016;19(4):316–328. PMID 27277331. https://pubmed.ncbi.nlm.nih.gov/27277331/

¹⁵ Winona, “Estrogen Patch,” verified August 18, 2026. https://bywinona.com/product/estrogen-patch

¹⁶ Winona, “Progesterone Capsules,” verified August 18, 2026. https://bywinona.com/product/progesterone-capsule

¹⁷ Winona FAQ, including age, billing, insurance, refund, and refill terms. Verified August 18, 2026. https://bywinona.com/faq

¹⁸ Winona, “Online Menopause Specialists,” current state list. Verified August 18, 2026. https://bywinona.com/online-menopause-specialists

¹⁹ Sesame, “Online Menopause Treatment,” medication, lab, insurance, video-care, and refund information. Verified August 18, 2026. https://sesamecare.com/service/menopause-treatment

²⁰ Winona Help Center, “Winona’s Compounding Pharmacies,” including the $50 outside-pharmacy platform fee. Updated January 22, 2026. https://help.bywinona.com/en/articles/5434454-winona-s-compounding-pharmacies

²¹ Newman MS, et al. “Comparative estrogen exposure from compounded transdermal estradiol creams and Food and Drug Administration-approved transdermal estradiol gels and patches.” Menopause. 2023. PMID 37847876. https://pubmed.ncbi.nlm.nih.gov/37847876/

²² Trustpilot, “Join Josie Reviews,” 3.8 from five reviews when checked August 18, 2026. https://www.trustpilot.com/review/joinjosie.com

²³ Join Josie, “Privacy Policy,” last updated January 15, 2026. https://www.joinjosie.com/legal/privacy-policy